The European Medicines Agency (EMA), the EU regulatory body in charge of approving COVID-19 vaccines, said today it was the victim of a cyber-attack. From a report: In a short two-paragraph statement posted on its website today, the agency discloses the security breach but said it couldn’t disclose any details about the intrusion due to an ongoing investigation. EMA is currently in the process of reviewing applications for two COVID-19 vaccines, one from US pharma giant Moderna, and a second developed in a collaboration between BioNTech and Pfizer. An EMA spokesperson did not return a request for comment seeking information if the attack targeted its vaccine approval process or if it was a financially-motivated attack like ransomware. Nonetheless, in a follow-up statement released on its own website, BioNTech said that “some documents relating to the regulatory submission for Pfizer and BioNTech’s COVID-19 vaccine candidate, BNT162b2, which has been stored on an EMA server, had been unlawfully accessed” during the attack, confirming that COVID-19 research was most likely the target of the attack.